Sign Up
OverviewAPI
T2 Biosystems, Inc. has been selected as a Phase 2 winner in the LymeX Diagnostics Prize, receiving $265,000 from the U.S. Department of Health and Human Services and the Steven & Alexandra Cohen Foundation. The company's T2Lyme™ Panel is a direct-from-blood molecular diagnostic test for detecting Borrelia burgdorferi, the bacteria causing Lyme disease. T2 Biosystems is committed to improving patient care through rapid detection of pathogens and antibiotic resistance genes.

Ask a question